Skip to main content
Clinical Trials/NCT03246256
NCT03246256UnknownNot Applicable

Recall of Information on Intravenous Thrombolysis in Acute Ischaemic Stroke Patients Given During Informed Consent: a Prospective Observational Study.

Charite University, Berlin, Germany5 sites in 1 country260 target enrollmentStarted: December 21, 2016Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Enrollment
260
Locations
5
Primary Endpoint
Recall of the designated facts given during informed consent procedure on intravenous thrombolysis after acute ischaemic stroke

Study Overview

Brief Summary

The aim of the study is to investigate the ability to recall information given during informed consent on intravenous thrombolysis in patients with acute ischaemic stroke.

Detailed Description

The purpose of this prospective multi-center study is to investigate whether patients with acute ischaemic stroke are able to recall information given before providing informed consent to intravenous thrombolysis after the end of treatment. Patients with acute ischaemic stroke will be compared to a group of relatives who witnessed the informed consent procedure of a relative with acute ischaemic stroke, stroke patients who were not treated with intravenous thrombolysis and patients without an ischaemic stroke but similiar risk factors (admitted to the Departement of Cardiology and Pneumology, Charité, Campus Benjamin Franklin, Berlin, Germany).

Study Design

Study Type
Observational
Observational Model
Other
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Recall of the designated facts given during informed consent procedure on intravenous thrombolysis after acute ischaemic stroke

Time Frame: Within 24 hours

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Karl Georg Haeusler

Consultant Neurologist

Wuerzburg University Hospital

Study Sites (5)

Loading locations...

Similar Trials